Search
for
Sort by
Research 31–60 of 1000+
- Cardiovascular risk factors and events in women with androgen excess
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Reporting on Adverse Clinical Events
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Epigenetic orchestration of RNA m<sup>6</sup>A methylation in wound healing and post-wound events
- What does the research say about androgen use and cerebrovascular events?
- Cutaneous signs in COVID ‐19 patients: A review
- Review of factors affecting the growth and survival of follicular grafts.
- Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium
- Female sexual dysfunction in androgenetic alopecia: Case-control study
- The application of optical technology in the diagnosis and therapy of oxidative stress-mediated hepatic ischemia-reperfusion injury
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Microvascular injury and regional perfusion vulnerability during recipient site creation in hair transplantation
- Acne in the adult female patient: a practical approach
- Gender-Affirming Hormone Therapy for Transgender Females
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Hormonal therapies for acne
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Interleukin-6 from Adipose-Derived Stem Cells Promotes Tissue Repair by the Increase of Cell Proliferation and Hair Follicles in Ischemia/Reperfusion-Treated Skin Flaps
- Therapeutic potential of hair follicle-derived stem cell intranasal transplantation in a rat model of ischemic stroke
- Ischemic modified albumin as a new biomarker in predicting of oxidative stress in alopecia areata
- Transgender and Migraine
- Spatial Gene Profiling in the Ischemic Heart
- Early Androgenetic Alopecia as a Predictor of Ischemic Heart Disease
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Forsythiaside A protects against focal cerebral ischemic injury by mediating the activation of the Nrf2 and endoplasmic reticulum stress pathways
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Pressure alopecia in living donors for liver transplantation
- Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases